Phase I Trial of Induction Paraplatin and Xeloda Followed by Concurrent Paraplatin and Xeloda With Intensity Modulated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Phase of Trial: Phase I
Latest Information Update: 06 Aug 2007
At a glance
- Drugs Capecitabine (Primary) ; Carboplatin
- Indications Head and neck cancer; Orofacial cancer; Oropharyngeal cancer
- Focus Adverse reactions
- 06 Aug 2007 Status changed from recruiting to completed.
- 08 Sep 2005 New trial record.